These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15670229)

  • 21. [Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases].
    Carra-Dalliere C; Horzinski L; Ayrignac X; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Seze J; Sedel F; Guennoc AM; Sartori E; Laplaud D; Antoine JC; Fogli A; Boespflug-Tanguy O; Labauge P
    Rev Neurol (Paris); 2011 Nov; 167(11):802-11. PubMed ID: 21676421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult-onset vanishing white matter leukoencephalopathy presenting as psychosis.
    Denier C; Orgibet A; Roffi F; Jouvent E; Buhl C; Niel F; Boespflug-Tanguy O; Said G; Ducreux D
    Neurology; 2007 May; 68(18):1538-9. PubMed ID: 17470759
    [No Abstract]   [Full Text] [Related]  

  • 23. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.
    Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS
    Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].
    Pan YX; Wu Y; Niu ZP; Jiang YW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vanishing white matter disease in French-Canadian patients from Quebec.
    Robinson MÈ; Rossignol E; Brais B; Rouleau G; Arbour JF; Bernard G
    Pediatr Neurol; 2014 Aug; 51(2):225-32. PubMed ID: 25079571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leucoencephalopathy with vanishing white matter may cause progressive myoclonus epilepsy.
    Jansen AC; Andermann E; Niel F; Creveaux I; Boespflug-Tanguy O; Andermann F
    Epilepsia; 2008 May; 49(5):910-3. PubMed ID: 18266750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia.
    Wei C; Qin Q; Chen F; Zhou A; Wang F; Zuo X; Chen R; Lyu J; Jia J
    BMC Neurol; 2019 Aug; 19(1):203. PubMed ID: 31438897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vanishing white matter disease associated with progressive macrocephaly.
    Pineda M; R-Palmero A; Baquero M; O'Callaghan M; Aracil A; van der Knaap M; Scheper GC
    Neuropediatrics; 2008 Feb; 39(1):29-32. PubMed ID: 18504679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up.
    Bektaş G; Yeşil G; Özkan MU; Yıldız EP; Uzunhan TA; Çalışkan M
    Clin Neurol Neurosurg; 2018 Aug; 171():190-193. PubMed ID: 29933199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vanishing white matter disease with different faces.
    Güngör G; Güngör O; Çakmaklı S; Maraş Genç H; İnce H; Yeşil G; Dilber C; Aydın K
    Childs Nerv Syst; 2020 Feb; 36(2):353-361. PubMed ID: 31385086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. eIF2B-related multisystem disorder in two sisters with atypical presentations.
    Lee JS; Lee S; Choi M; Lim BC; Choi J; Kim KJ; Cheon JE; Kim IO; Chae JH
    Eur J Paediatr Neurol; 2017 Mar; 21(2):404-409. PubMed ID: 28041799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease.
    Wortham NC; Proud CG
    BMC Med Genet; 2015 Aug; 16():64. PubMed ID: 26285592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early MR imaging and spectroscopy appearance of eIF2B-related leukoencephalopathy.
    Mascalchi M; De Grandis D; Ginestroni A; Pratesi A; Della Nave R; Scheper GC; van der Knaap MS
    Neurology; 2006 Aug; 67(3):537-8. PubMed ID: 16894129
    [No Abstract]   [Full Text] [Related]  

  • 34. A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation.
    Fogli A; Dionisi-Vici C; Deodato F; Bartuli A; Boespflug-Tanguy O; Bertini E
    Neurology; 2002 Dec; 59(12):1966-8. PubMed ID: 12499492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of ten novel mutations in patients with eIF2B-related disorders.
    Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J
    Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. eIF2B-related disorders: antenatal onset and involvement of multiple organs.
    van der Knaap MS; van Berkel CG; Herms J; van Coster R; Baethmann M; Naidu S; Boltshauser E; Willemsen MA; Plecko B; Hoffmann GF; Proud CG; Scheper GC; Pronk JC
    Am J Hum Genet; 2003 Nov; 73(5):1199-207. PubMed ID: 14566705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of ovarioleukodystrophy without eIF2B mutations.
    Gaudiano C; Di Perri C; Scali O; Rufa A; Battisti C; De Stefano N; Federico A
    J Neurol Sci; 2008 May; 268(1-2):183-6. PubMed ID: 18061208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human-induced pluripotent stem cell-derived cerebral organoid of leukoencephalopathy with vanishing white matter.
    Deng J; Zhang J; Gao K; Zhou L; Jiang Y; Wang J; Wu Y
    CNS Neurosci Ther; 2023 Apr; 29(4):1049-1066. PubMed ID: 36650674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vanishing White Matter With Hepatomegaly and Hypertriglyceridemia Attacks.
    Unal O; Ozgen B; Orhan D; Tokatli A; Hismi BO; Dursun A; Coskun T; Kalkanoglu-Sivri HS
    J Child Neurol; 2013 Nov; 28(11):1509-1512. PubMed ID: 22992991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
    Fogli A; Schiffmann R; Hugendubler L; Combes P; Bertini E; Rodriguez D; Kimball SR; Boespflug-Tanguy O
    Eur J Hum Genet; 2004 Jul; 12(7):561-6. PubMed ID: 15054402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.